This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Tikiz, H. Articles by Kütük, E. Search for Related Content PubMed PubMed Citation Articles by Tikiz, H. Articles by Kütük, E. Social Bookmarking                   What's this?

Diabetes Mellitus Adversely Affects the Outcomes of Thrombolytic Therapy in Patients with Acute Myocardial Infarction

Ugur Tezcan, MD

Mehmet Ileri, MD

Yücel Balbay, MD

Ramazan Atak, MD

Emine Kütük, MD

This study was performed to evaluate whether coexistent diabetes mellitus has any adverse effect on the outcomes of thrombolytic therapy in patients with acute myocardial infarction. Although the early reperfusion rates were similar between the two groups of patients who had acute myocardial infarction with and without diabetes mellitus (42% vs 45.4%, p > 0.05), the results of late angiographic examination showed a significantly lower rate of patency in infarct- related coronary artery (defined as TIMI 3 flow) in diabetics compared to nondiabetics (28.9% vs 41.3%, p< 0.001). The global left ventricular function was also poorer in diabetics (left ventricular wall motion score was 18.6 ±7.3 in diabetics and 14.1 ±4.6 in nondiabetics, p < 0.01 1).

Angiology, Vol. 54, No. 4, 449-456 (2003)
DOI: 10.1177/000331970305400409


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?